Lionco Pharmaceutical Group Co.,Ltd. (SHSE:603669) announces a share repurchase program. Under the program, the company will repurchase up to CNY 100 million worth of its shares. The shares will be purchased at a price not exceeding CNY 9.64 per share.

50% of the repurchased shares will be used for the implementation of ESOP and 50% of the repurchased shares will be used for equity incentive plan. The program will be valid for 12 months.